Adi David1, David Hausner1,2, Moshe Frenkel3,4. 1. Tal Center for Integrative Medicine, Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. 2. Palliative Care Service, Chaim Sheba Medical Center, Ramat Gan, Israel. 3. Department of Family Medicine, University of Texas Medical Branch, Galveston, TX, USA. frenkelm@netvision.net.il. 4. Complementary and Integrative Medicine Service, Oncology Division, Rambam Health Care Campus, Hashoftim 1 B, Zichron Yaacov, 30900, Haifa, Israel. frenkelm@netvision.net.il.
Abstract
PURPOSE OF REVIEW: This review aims to assess recent data on possible effective and safe complementary and integrative medicine (CIM) modalities that can be of help to patients affected by cancer that suffer from cancer-related fatigue (CRF). RECENT FINDINGS: Cancer-related fatigue (CRF) is one of the most common, persistent, and challenging symptoms among cancer patients and survivors. Many world-leading cancer centers incorporate CIM into routine cancer care including integrating multiple approaches to address CRF. Approaches that are supported by clinical evidence on the use of CIM during and following conventional oncology treatments are being discussed in this review. The review suggests that some CIM modalities might have a potential role in alleviating cancer-related fatigue. These modalities include acupuncture, touch therapies, nutrition, nutritional supplements, stress reduction, homeopathy, and circadian rhythm management. Additional research is still needed to better support the process of integrating CIM into a routine approach to cancer-related fatigue.
PURPOSE OF REVIEW: This review aims to assess recent data on possible effective and safe complementary and integrative medicine (CIM) modalities that can be of help to patients affected by cancer that suffer from cancer-related fatigue (CRF). RECENT FINDINGS: Cancer-related fatigue (CRF) is one of the most common, persistent, and challenging symptoms among cancer patients and survivors. Many world-leading cancer centers incorporate CIM into routine cancer care including integrating multiple approaches to address CRF. Approaches that are supported by clinical evidence on the use of CIM during and following conventional oncology treatments are being discussed in this review. The review suggests that some CIM modalities might have a potential role in alleviating cancer-related fatigue. These modalities include acupuncture, touch therapies, nutrition, nutritional supplements, stress reduction, homeopathy, and circadian rhythm management. Additional research is still needed to better support the process of integrating CIM into a routine approach to cancer-related fatigue.
Authors: Ariel B Neikrug; Michelle Rissling; Vera Trofimenko; Lianqi Liu; Loki Natarajan; Susan Lawton; Barbara A Parker; Sonia Ancoli-Israel Journal: Behav Sleep Med Date: 2012 Impact factor: 2.964
Authors: Jillian A Johnson; Sheila N Garland; Linda E Carlson; Josée Savard; J Steven A Simpson; Sonia Ancoli-Israel; Tavis S Campbell Journal: J Cancer Surviv Date: 2017-11-10 Impact factor: 4.442
Authors: Xin Shelley Wang; Fengmin Zhao; Michael J Fisch; Ann M O'Mara; David Cella; Tito R Mendoza; Charles S Cleeland Journal: Cancer Date: 2014-02-01 Impact factor: 6.860
Authors: Suzanna Maria Zick; Heather Zwickey; Lisa Wood; Bradley Foerster; Tohfa Khabir; Benjamin Wright; Eric Ichesco; Ananda Sen; Richard Edmund Harris Journal: Brain Imaging Behav Date: 2014-12 Impact factor: 3.978
Authors: Kristin L Campbell; Kerri M Winters-Stone; Joachim Wiskemann; Anne M May; Anna L Schwartz; Kerry S Courneya; David S Zucker; Charles E Matthews; Jennifer A Ligibel; Lynn H Gerber; G Stephen Morris; Alpa V Patel; Trisha F Hue; Frank M Perna; Kathryn H Schmitz Journal: Med Sci Sports Exerc Date: 2019-11 Impact factor: 5.411
Authors: Karen M Mustian; Catherine M Alfano; Charles Heckler; Amber S Kleckner; Ian R Kleckner; Corinne R Leach; David Mohr; Oxana G Palesh; Luke J Peppone; Barbara F Piper; John Scarpato; Tenbroeck Smith; Lisa K Sprod; Suzanne M Miller Journal: JAMA Oncol Date: 2017-07-01 Impact factor: 31.777
Authors: Kathryn H Schmitz; Nicole L Stout; Melissa Maitin-Shepard; Anna Campbell; Anna L Schwartz; Chloe Grimmett; Jeffrey A Meyerhardt; Jonas M Sokolof Journal: Cancer Date: 2020-10-22 Impact factor: 6.860